BFA
OPTR

BlackRock Fund Advisors’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

BlackRock Fund Advisors’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,070,787
Closed -$26.1M – 3899
2013
Q3 		$26.1M Buy
2,070,787
+231,532
+13% +$3.07M 0.01% 1797
2013
Q2 		$26.6M Buy
+1,839,255
New +$26.8M 0.01% 1644

BlackRock Fund Advisors's OPTR Position: Q4 2013 in Review

BlackRock Fund Advisors sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,070,787 shares — an estimated $26.1M sold.

BlackRock Fund Advisors first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $26.6M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • BlackRock Fund Advisors reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • BlackRock Fund Advisors sold 2,070,787 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $26.1M.
  • BlackRock Fund Advisors first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • BlackRock Fund Advisors's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $26.6M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on BlackRock Fund Advisors's 13F filing for Q4 2013, filed 12 Feb 2014.